Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,621 INR | +1.02% | +3.54% | +28.67% |
Mar. 19 | Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia | MT |
Mar. 19 | Sun Pharmaceutical's Acne Drug Gets Approval in Australia | MT |
Sales 2024 * | 485B 5.82B | Sales 2025 * | 538B 6.46B | Capitalization | 3,888B 46.65B |
---|---|---|---|---|---|
Net income 2024 * | 93.16B 1.12B | Net income 2025 * | 112B 1.35B | EV / Sales 2024 * | 7.79 x |
Net cash position 2024 * | 108B 1.3B | Net cash position 2025 * | 166B 2B | EV / Sales 2025 * | 6.91 x |
P/E ratio 2024 * |
41.8
x | P/E ratio 2025 * |
34.6
x | Employees | 41,000 |
Yield 2024 * |
0.75% | Yield 2025 * |
0.87% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | +1.02% | ||
1 week | +3.54% | ||
Current month | +2.70% | ||
1 month | +2.97% | ||
3 months | +28.40% | ||
6 months | +43.12% | ||
Current year | +28.67% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1,621 | +1.02% | 4,427,587 |
24-03-27 | 1,604 | +0.38% | 2,530,169 |
24-03-26 | 1,598 | -0.67% | 3,649,049 |
24-03-22 | 1,609 | +2.79% | 4,941,447 |
24-03-21 | 1,565 | +1.02% | 2,567,975 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.67% | 46.63B | |
+19.30% | 22.49B | |
+20.11% | 14.49B | |
+0.55% | 12.98B | |
+46.16% | 12.16B | |
-2.44% | 7.69B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.15B | |
+5.83% | 4.64B |